FLUVOXAMINE VIATRIS 100 mg, film-coated tablet scored 15 tablets
Active ingredients: Fluvoxamine maleate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored15 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FLUVOXAMINE VIATRIS 100 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 15 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 16 Jan 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68766984CIP73564708CIP133400935647085Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE FLUVOXAMINEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.